CLEVELAND, Aug. 16, 2021, /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced the grant of 91,240 restricted stock units to Arun Viswanath, effective August 16, 2021, as an inducement material to entering into employment with the Company as Vice President, Software Engineering. The award was granted in accordance with Nasdaq Listing Rule 5635(c)(4) and approved by the Compensation Committee of the Company’s Board of Directors.
The award is subject to the terms and conditions of the ViewRay, Inc. 2018 Equity Inducement Award Program and Amended and Restated 2015 Equity Incentive Award Plan and Mr. Viswanath’s related award agreement. These terms include service-based vesting requirements, with the restricted stock units vesting over three years.
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
Director, Marketing Communications